These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24615943)

  • 1. Modulation of estrogen and epidermal growth factor receptors by rosemary extract in breast cancer cells.
    González-Vallinas M; Molina S; Vicente G; Sánchez-Martínez R; Vargas T; García-Risco MR; Fornari T; Reglero G; Ramírez de Molina A
    Electrophoresis; 2014 Jun; 35(11):1719-27. PubMed ID: 24615943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells.
    González-Vallinas M; Molina S; Vicente G; de la Cueva A; Vargas T; Santoyo S; García-Risco MR; Fornari T; Reglero G; Ramírez de Molina A
    Pharmacol Res; 2013 Jun; 72():61-8. PubMed ID: 23557932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin.
    Einbond LS; Wu HA; Kashiwazaki R; He K; Roller M; Su T; Wang X; Goldsberry S
    Fitoterapia; 2012 Oct; 83(7):1160-8. PubMed ID: 22828666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy.
    González-Vallinas M; Reglero G; Ramírez de Molina A
    Nutr Cancer; 2015; 67(8):1221-9. PubMed ID: 26452641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
    Yang Z; Barnes CJ; Kumar R
    Clin Cancer Res; 2004 Jun; 10(11):3621-8. PubMed ID: 15173068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression and treatment of HER2-positive breast cancer.
    Davoli A; Hocevar BA; Brown TL
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):611-23. PubMed ID: 20087739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways.
    Saggar JK; Chen J; Corey P; Thompson LU
    Mol Nutr Food Res; 2010 Mar; 54(3):415-25. PubMed ID: 19904759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosemary Extract Inhibits Proliferation, Survival, Akt, and mTOR Signaling in Triple-Negative Breast Cancer Cells.
    Jaglanian A; Tsiani E
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer Effects of Rosemary (Rosmarinus officinalis L.) Extract and Rosemary Extract Polyphenols.
    Moore J; Yousef M; Tsiani E
    Nutrients; 2016 Nov; 8(11):. PubMed ID: 27869665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
    Chang SB; Miron P; Miron A; Iglehart JD
    J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells.
    Do MT; Kim HG; Choi JH; Khanal T; Park BH; Tran TP; Jeong TC; Jeong HG
    Food Chem; 2013 Dec; 141(3):2591-9. PubMed ID: 23870999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved neuroprotective effects by combining Bacopa monnieri and Rosmarinus officinalis supercritical CO2 extracts.
    Ramachandran C; Quirin KW; Escalon E; Melnick SJ
    J Evid Based Complementary Altern Med; 2014 Apr; 19(2):119-27. PubMed ID: 24647092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen.
    Truan JS; Chen JM; Thompson LU
    Mol Nutr Food Res; 2010 Oct; 54(10):1414-21. PubMed ID: 20425756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells.
    McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S
    J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone receptor loss correlates with human epidermal growth factor receptor 2 overexpression in estrogen receptor-positive breast cancer.
    Kim HJ; Cui X; Hilsenbeck SG; Lee AV
    Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1013s-1018s. PubMed ID: 16467118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells.
    Lee EJ; Oh SY; Sung MK
    Food Chem Toxicol; 2012 Nov; 50(11):4136-43. PubMed ID: 22926442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance.
    Dua R; Zhang J; Nhonthachit P; Penuel E; Petropoulos C; Parry G
    Breast Cancer Res Treat; 2010 Aug; 122(3):685-97. PubMed ID: 19859802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response.
    Lazaro G; Smith C; Goddard L; Jordan N; McClelland R; Barrett-Lee P; Nicholson RI; Hiscox S
    Endocr Relat Cancer; 2013 Oct; 20(5):691-704. PubMed ID: 23900794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.